-
Solentim names Mark Truesdale as new CEO
Bournemouth, UK, 2nd March 2020 / Sciad Newswire / Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO. Mark joined Solentim in October 2019 as Chief Marketing Officer. As CEO, Mark will work with the Company founders and executive team to deliver and execute a…
-
Building Life Science Adventures: A Conference on Creating the Best Careers and Teams
Cambridge, UK, 25th February 2020 / Sciad Newswire / One Nucleus is pleased to announce the launch of a new careers conference in Cambridge for students, employers and employees in the life sciences industry: “Building Life Science Adventures: A Conference on Creating the Best Careers and Teams.” The one-day event will be a chance to fill knowledge gaps and share best…
-
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
Cambridge and Leeds, UK, 25th February 2020 / Sciad Newswire / Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies. The aim of…
-
Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis
Glasgow, Scotland, 24th February 2020 / Sciad Newswire / Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETERTM wearable biosensor device. Altair Medical’s RESPMETER is a chest-worn wireless sensor that accurately detects when someone is suffering…
-
Minimal pulsation a must for transferring viscous suppository mass
The manufacture of suppositories requires a steady transfer of viscous mass in a low pulsation environment. The slightest fluctuation in temperature, or pressure, can cause the mass to harden, affecting the quality of the final product. Dr. Pfleger Arzneimittel is behind numerous prescription medicines in urology, dermatology and pain-relief as well as many recognised over…
-
Domainex announces the appointment of Tom Mander as Chief Executive Officer
Cambridge, UK, 13th February 2020 / Sciad Newswire / Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020. Tom has nearly 30 years of experience in small-molecule drug discovery, and joined Domainex as Chief Operating Officer in…
-
Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites
Slough/Dundee, UK, 3rd February 2020 / Sciad Newswire / Hypha Discovery Limited, the leading specialist CRO for drug metabolite provision, and Cypex Limited, experts in the provision of recombinant xenobiotic metabolising enzymes, have formed a partnership wherein Hypha can scale-up and purify metabolites made by Cypex enzymes (available as Bactosomes). The partnership utilises the expert services Hypha Discovery already…
-
Full FDA compliance of Certa 250 pump enables US exports for leading UK natural healthcare manufacturer
One of the UK’s leading natural healthcare manufacturers has integrated the MasoSine Certa 250 pump by Watson-Marlow Fluid Technology Group (WMFTG) into its pharmaceutical creams manufacturing process. The pump satisfies all FDA requirements, with full clean-in-place (CIP) capabilities, successfully enabling the Company to export its natural healthcare products to the US and expand its global presence. Exporting to the US…
-
BHF announces shortlist for £30m research prize at start of defining decade for CVD
Proposals feature a soft robotic heart, a cure for genetic heart disease, a heart attack vaccine and next generation health tech. London, UK, 23rd January 2020 / Sciad Newswire / The British Heart Foundation (BHF) today announced its shortlist of four research projects competing for a single £30 million award. The charity says it is one of…
-
New transfer tubing from BioPure provides reliable fluid transfer solution for biopharmaceutical applications
Falmouth, UK, 20th January 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) has launched BioPure silicone transfer tubing to provide a safe, reliable and value-based solution for a wide range of bioprocess fluid transfer applications. Biopharmaceutical processes are among the most critical in the world, so having confidence in the quality and cleanliness of manufacturing materials is essential. Using WMFTG’s…